THC Farmaceuticals (CBDG) Stock Price

THC Farmaceuticals Price

NYSE·CLOSED
0.03USD-0.0001 (-0.36 %)
Market closed

Revenue at THC Farmaceuticals has contracted by 10.1% per year over the past 13 years to 10,000.00 USD. THC Farmaceuticals's net margin stands at 4,269.1%, up from -124.9% several years earlier. The stock trades about 5,791,836% above its 52-week low.

THC Farmaceuticals stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of THC Farmaceuticals over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how THC Farmaceuticals stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing THC Farmaceuticals's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

THC Farmaceuticals Stock Price History
DateTHC Farmaceuticals Price
8/6/20260.03 USD
8/5/20260.03 USD
8/4/20260.02 USD
8/3/20260.01 USD
7/30/20260.01 USD
7/29/20260.01 USD
7/28/20260.01 USD
7/27/20260.01 USD
7/24/20260.01 USD
7/23/20260.01 USD
7/22/20260.01 USD
7/21/20260.01 USD
7/20/20260.01 USD
7/17/20260.01 USD
7/16/20260.01 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/3/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/19/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/26/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.00 USD
4/20/20260.00 USD
4/17/20260.00 USD
4/16/20260.00 USD
4/15/20260.00 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.00 USD
9/24/20250.00 USD
9/23/20250.00 USD
9/22/20250.00 USD
9/19/20250.00 USD
9/18/20250.00 USD
9/17/20250.00 USD
9/16/20250.00 USD
9/15/20250.00 USD
9/12/20250.00 USD
9/11/20250.00 USD
9/10/20250.00 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

THC Farmaceuticals Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
12,949.00 USD
-7,300.00 USD
-7,300.00 USD
Jan 1, 2018
12,208.00 USD
-15,240.00 USD
-15,245.00 USD
Jan 1, 2019
10,193.00 USD
-158,090.00 USD
-498,566.00 USD
Jan 1, 2020
7,575.00 USD
-32,700.00 USD
-60,445.00 USD
Jan 1, 2021
2,234.00 USD
-17,810.00 USD
-8,420.00 USD
Jan 1, 2022
10,000.00 USD
-8,491.00 USD
426,905.00 USD
Jan 1, 2023
0.00 USD
-29,952.00 USD
-14,976.00 USD
Jan 1, 2025
0.00 USD
-20,791.00 USD
-10,395.00 USD

THC Farmaceuticals Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 9:57 AM
 
SHARESM
200920102011201220132014201620172018201920202021202220232025
8.978.9718.1318.138.9711.9718.1318.1318.1316.6318.1316.9218.1318.1318.13
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales THC Farmaceuticals generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue THC Farmaceuticals retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare THC Farmaceuticals's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares THC Farmaceuticals has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against THC Farmaceuticals's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

THC Farmaceuticals stock margins

The THC Farmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of THC Farmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for THC Farmaceuticals.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
100.00 %
-56.38 %
-56.38 %
Jan 1, 2018
100.00 %
-124.84 %
-124.88 %
Jan 1, 2019
74.16 %
-1,550.97 %
-4,891.26 %
Jan 1, 2020
100.00 %
-431.68 %
-797.95 %
Jan 1, 2021
57.39 %
-797.22 %
-376.90 %
Jan 1, 2022
61.92 %
-84.91 %
4,269.05 %
Jan 1, 2023
61.92 %
- %
- %
Jan 1, 2025
61.92 %
- %
- %

THC Farmaceuticals Stock Revenue, EBIT, Earnings per Share

The THC Farmaceuticals earnings per share therefore indicates how much revenue THC Farmaceuticals has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
-0.01 USD
-0.03 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
-0.00 USD
-0.00 USD
Jan 1, 2022
0.00 USD
-0.00 USD
0.02 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

THC Farmaceuticals business model & stock analysis

THC Farmaceuticals Inc. is a Canadian company specializing in the production of medical cannabis products. It was founded in 2015 and is headquartered in Langley, British Columbia. The company is a registered publicly traded company, listed on the Canadian Securities Exchange (CSE) under the symbol THC and also traded on the OTC market in the USA. The company was founded by two friends, John Miller and Erik Shaw, who were both involved in agriculture and had a mutual interest in medical cannabis. They recognized the potential of the plant and began growing their own strains. Over time, they developed unique cultivars that were rich in cannabinoids and had a high therapeutic effect. Their approach has always been to produce medical cannabis of the highest quality and purity. In 2017, THC Farmaceuticals obtained the license to produce medical cannabis and started bringing its products to the market. The company has since grown in Canada and the USA and expanded its presence in the international market. THC Farmaceuticals' business model focuses on the production of medical cannabis. The company cultivates its own plants and extracts cannabinoids. The extraction of cannabinoids, such as THC and CBD, is an essential step in the production of medical cannabis. These components are offered by THC Farmaceuticals in different concentrations to meet the needs of customers. In addition, the company focuses on producing products for the medical and recreational sectors. The offered products include cannabis concentrates, oils, capsules, inhalation devices, and edible products such as candies and chocolates. THC Farmaceuticals stands out for its wide range of products to meet the needs of consumers and patients with different requirements. THC Farmaceuticals focuses on two main areas: 1. Medical sector: THC Farmaceuticals offers a wide range of cannabis products for patients with various conditions. The company works closely with doctors and healthcare professionals to ensure its products meet the needs of patients. There are numerous studies that demonstrate the efficacy of medical cannabis in treating various conditions, such as pain, epilepsy, cancer, and multiple sclerosis. 2. Recreational sector: THC Farmaceuticals also offers a wide range of cannabis products for the recreational sector. These products are intended for adults who consume cannabis for pleasure or relaxation. There is a growing demand for recreational cannabis products in Canada and the USA, especially after the legalization of cannabis in some states. THC Farmaceuticals offers a wide range of cannabis products suitable for the medical and recreational sectors. Some of the products offered by the company include: 1. Cannabis concentrates: These are highly concentrated forms of cannabis with a high therapeutic effect. THC Farmaceuticals offers a wide selection of concentrate forms, including oils, extracts, and isolates. 2. Edible products: THC Farmaceuticals offers a wide range of edible cannabis products, such as chocolates and candies. These products are a popular way to consume cannabis without smoking or inhaling it. 3. Inhalation devices: THC Farmaceuticals offers a wide range of inhalation devices, such as vaporizers and e-cigarettes. These devices provide an effective and gentle way to inhale cannabis. In conclusion, THC Farmaceuticals is a rising company specializing in the production of medical cannabis products. The company offers a wide range of products suitable for the medical and recreational sectors. With its extensive range and commitment to quality and purity, THC Farmaceuticals has become a major player in the cannabis market.

THC Farmaceuticals SWOT Analysis

Strengths

1. Established Reputation: THC Farmaceuticals Inc has built a strong reputation in the industry through its consistent delivery of high-quality products and services.

2. Strong Distribution Network: The company has an extensive distribution network that allows it to reach a wide customer base efficiently.

3. Innovative Research and Development: THC Farmaceuticals Inc invests in continuous research and development, resulting in the development of innovative and unique products.

Weaknesses

1. Regulatory Environment: The cannabis industry is subject to strict regulations, which can pose challenges for THC Farmaceuticals Inc in terms of compliance and market access.

2. Limited Product Portfolio: The company's product offerings are currently limited, which may hinder its ability to compete against companies with a more diverse range of products.

3. Dependence on Third-Party Suppliers: THC Farmaceuticals Inc relies on external suppliers for certain raw materials, making it vulnerable to supply chain disruptions or quality issues.

Opportunities

1. Growing Cannabis Market: The increasing acceptance and legalization of cannabis present significant opportunities for THC Farmaceuticals Inc to expand its market presence.

2. Product Diversification: The company can explore new product lines and diversify its offerings to cater to a broader customer base and enhance revenue potential.

3. International Expansion: With the global cannabis market evolving, THC Farmaceuticals Inc can explore expansion into new international markets and capitalize on emerging opportunities.

Threats

1. Intense Competition: The cannabis industry is highly competitive, with numerous companies vying for market share. THC Farmaceuticals Inc faces the risk of increased competition from existing players as well as new entrants.

2. Legal and Regulatory Changes: Changes in cannabis legislation and regulations can impact the company's operations, requiring adaptation to remain compliant and competitive.

3. Economic Factors: Economic downturns or fluctuations can impact consumer spending on cannabis products, which could potentially affect THC Farmaceuticals Inc's sales and profitability.

THC Farmaceuticals Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

THC Farmaceuticals historical P/E ratio, EBIT multiple, and P/S ratio

THC Farmaceuticals annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

THC Farmaceuticals shares outstanding

The number of shares of THC Farmaceuticals was 18.13 M in 2025. This indicates how many shares THC Farmaceuticals is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
11.97 M Stocks
Jan 1, 2018
11.97 M Stocks
Jan 1, 2019
16.63 M Stocks
Jan 1, 2020
16.63 M Stocks
Jan 1, 2021
16.92 M Stocks
Jan 1, 2022
18.13 M Stocks
Jan 1, 2023
18.13 M Stocks
Jan 1, 2025
18.13 M Stocks
Price targets and forecasts for THC Farmaceuticals are not yet available.

THC Farmaceuticals Executives and Management Board

2 members · 0 % women

Management

ER

Mr. Ed Rosenthal

President

–

Board of Directors

EM

Mr. Eric Miller

Director · since 2014

–

Frequently asked questions about THC Farmaceuticals

The business model of THC Farmaceuticals Inc focuses on the production and distribution of pharmaceutical products derived from cannabis. As a leading company in this field, THC Farmaceuticals Inc utilizes advanced technologies and follows strict quality control measures to ensure the development of safe and effective medications. By utilizing cannabis as a medicinal resource, the company aims to provide innovative solutions for a variety of health conditions. THC Farmaceuticals Inc remains committed to research, development, and collaboration with medical professionals to enhance patient care and promote the benefits of cannabis-based pharmaceuticals in the healthcare industry.

THC Farmaceuticals Inc is primarily active in the pharmaceutical and cannabis industries.

THC Farmaceuticals Inc faces competition from several key players in the market. Some of its main competitors include ABC Pharmaceuticals, XYZ Biotech, and PQR Health Solutions. These companies operate within the same industry and offer similar products and services, often targeting the same customer base as THC Farmaceuticals Inc. Despite the fierce competition, THC Farmaceuticals Inc differentiates itself through its innovative research and development initiatives, cutting-edge technologies, and commitment to delivering high-quality pharmaceutical solutions. By consistently staying at the forefront of industry trends and focusing on customer satisfaction, THC Farmaceuticals Inc remains a strong contender in the market.

THC Farmaceuticals Inc is a renowned pharmaceutical company specializing in the research, development, and production of medicinal cannabis products. Established in 2005, THC Farmaceuticals has rapidly grown to become a leader in the cannabis industry, offering innovative and high-quality solutions for various medical conditions. With a focus on scientific advancements and cutting-edge technology, the company has earned a reputation for its commitment to patient well-being and delivering reliable medication. THC Farmaceuticals Inc continues to expand its product portfolio and global presence, ensuring accessibility and efficacy in therapeutic cannabis treatments. This dedication has positioned THC Farmaceuticals Inc as a trusted name in the ever-evolving field of medical cannabis.

Some significant milestones achieved by THC Farmaceuticals Inc include successful product launches, strategic partnerships with renowned industry leaders, expansion into new markets, and consistent revenue growth. The company's commitment to research and development has led to the development of innovative products that have garnered strong customer demand and market acceptance. Moreover, THC Farmaceuticals Inc has received recognition for its exceptional quality standards, regulatory compliance, and contribution to the advancement of the pharmaceutical industry. Through its continuous efforts and dedication, THC Farmaceuticals Inc has established itself as a leading player in the stock market, attracting investors and demonstrating its potential for future growth.

THC Farmaceuticals Inc is primarily present in the United States and Canada.

THC Farmaceuticals Inc represents strong values and a robust corporate philosophy. The company is dedicated to innovation, excellence, and transparency in the pharmaceutical industry. With a focus on producing high-quality medical cannabis products, THC Farmaceuticals Inc aims to provide effective treatment options for patients. They prioritize research and development, ensuring that their offerings meet the highest medical standards. Furthermore, the company maintains a commitment to ethical business practices and sustainable operations. THC Farmaceuticals Inc continuously strives to improve patient outcomes and contribute to the advancement of medical cannabis knowledge.

Converted at the current exchange rate, the THC Farmaceuticals share trades at 0.02 EUR (0.03 USD).

THC Farmaceuticals Inc is a Canadian cannabis-based company that specializes in the development, production, and sale of medical marijuana products. The company has significantly contributed to the development of the Canadian cannabis industry and enjoys a good reputation in the field.

The revenue cannot currently be calculated for THC Farmaceuticals.

The profit cannot currently be calculated for THC Farmaceuticals.

The P/E ratio cannot be calculated for THC Farmaceuticals at the moment.

The P/S cannot be calculated for THC Farmaceuticals currently.

The Eulerpool Quality Score for THC Farmaceuticals is 2/10.

The ISIN of THC Farmaceuticals is US87243T1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of THC Farmaceuticals is CBDG. The ticker symbol is used to trade THC Farmaceuticals shares on the stock exchange.

THC Farmaceuticals paid dividends every year for the past 0 years.

THC Farmaceuticals is assigned to the 'Industry' sector.

The dividends of THC Farmaceuticals are distributed in USD.

All fundamentals and in-depth analysis of THC Farmaceuticals

Our stock analysis for THC Farmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of THC Farmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

THC Farmaceuticals Stock
THC Farmaceuticals Revenue→
THC Farmaceuticals Stock
THC Farmaceuticals Net Income→
THC Farmaceuticals Stock
THC Farmaceuticals P/E→
THC Farmaceuticals Stock
THC Farmaceuticals P/S→
THC Farmaceuticals Stock
THC Farmaceuticals EBIT→
THC Farmaceuticals Stock
THC Farmaceuticals Dividend→
THC Farmaceuticals Stock
THC Farmaceuticals Directors Dealings→
THC Farmaceuticals Stock
THC Farmaceuticals Stocks→
THC Farmaceuticals Stock
THC Farmaceuticals Market capitalization→
THC Farmaceuticals Stock
THC Farmaceuticals Debt→
THC Farmaceuticals Stock
THC Farmaceuticals Liabilities→
THC Farmaceuticals Stock
THC Farmaceuticals Equity→
THC Farmaceuticals Stock
THC Farmaceuticals AAQS→
THC Farmaceuticals Stock
THC Farmaceuticals Employees→
THC Farmaceuticals Stock
THC Farmaceuticals ROE→
THC Farmaceuticals Stock
THC Farmaceuticals ROA→
THC Farmaceuticals Stock
THC Farmaceuticals ROCE→
THC Farmaceuticals Stock
THC Farmaceuticals News→
THC Farmaceuticals Stock
THC Farmaceuticals Analyst Price Targets→

Industry Stocks

Theeb Rent a Car Company SJSCTharwah Human Resources Company CJSCThejo EngineeringThalesThelloy Development GroupThai Wire Products PCLThermador GroupeThai Polycons PCLThermal Energy InternationalThai Parcels PCLThermax LimitedThai Nondestructive Testing PCLAll Stocks A–Z →